HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.

AuthorsAnne-Els van de Logt, Karine Dahan, Alexandra Rousseau, Renate van der Molen, Hanna Debiec, Pierre Ronco, Jack Wetzels
JournalKidney international (Kidney Int) Vol. 93 Issue 4 Pg. 1016-1017 (04 2018) ISSN: 1523-1755 [Electronic] United States
PMID29571438 (Publication Type: Comparative Study, Letter, Multicenter Study)
Chemical References
  • Autoantibodies
  • Biomarkers
  • Immunosuppressive Agents
  • PLA2R1 protein, human
  • Receptors, Phospholipase A2
  • Rituximab
  • Cyclophosphamide
Topics
  • Autoantibodies (blood, immunology)
  • Autoimmunity (drug effects)
  • Biomarkers (blood)
  • Cyclophosphamide (therapeutic use)
  • France
  • Glomerulonephritis, Membranous (blood, diagnosis, drug therapy, immunology)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Netherlands
  • Receptors, Phospholipase A2 (immunology)
  • Remission Induction
  • Rituximab (therapeutic use)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: